News & Publications Share Print Featured Story This Startup Just Raised $70 Million To Grow Tiny Tumors That Create Personalized Cancer Treatments Forbes November 17, 2021 Read More Xilis in the News Xilis Aims to Demonstrate Ability of Drug Screening Micro-Tumors to Personalize Cancer Therapy Precision Oncology May 25, 2022 Read More Check out these startups from Pear’s Demo Day (there’s usually a breakout or two in the bunch) TechCrunch October 15, 2021 Read More Two Duke professors raise $70 million in funds to research experimental cancer treatment … Duke Chronicle October 8, 2021 Read More load more Press Releases Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million Business Wire July 13, 2022 Read More Xilis Announces Breast Cancer Oncologist Dr. Daniel F. Hayes to Join Clinical Advisory Board Business Wire June 8, 2022 Read More Xilis Participates in €325MM Oncode-PACT Consortium to Accelerate the Development of Cancer Drugs Business Wire May 3, 2022 Read More Xilis Presents Data at ESMO 2021 Demonstrating Capabilities of MicroOrganoSphere™ Technology for Cancer Drug Screening Business Wire September 20, 2021 Read More Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and … Business Wire July 8, 2021 Read More Publications A path to translation: How 3D patient tumor avatars enable next generation precision oncology ScienceDirect October 20, 2022 Read More Rapid tissue prototyping with micro-organospheres Cell Stem Cell September 13, 2022 Read More Patient-derived micro-organospheres enable clinical precision oncology Cell Stem Cell June 2, 2022 Read More
